4.3 Article Proceedings Paper

Understanding incidental findings in the context of genetics and genomics

期刊

JOURNAL OF LAW MEDICINE & ETHICS
卷 36, 期 2, 页码 280-+

出版社

SAGE PUBLICATIONS INC
DOI: 10.1111/j.1748-720X.2008.00270.x

关键词

-

资金

  1. NHGRI NIH HHS [P50 HG003389-04, P50 HG003389, P50 HG003389-03S1, R01 HG 003178, 5 P50 HG 3389-04, P50 HG003389-03, R01 HG003178-01A1, R01 HG003178] Funding Source: Medline

向作者/读者索取更多资源

Human genetic and genomic research can yield information that may be of clinical relevance to the individuals who participate as subjects of the research. It has been common practice among researchers to notify participants during the informed consent process that no individual results will be disclosed, incidental or otherwise. However, as genetic information obtained in research becomes orders of magnitude more voluminous, increasingly accessible online, and more informative, this precedent may no longer be appropriate. There is not yet consensus on the responsibilities of researchers to disclose individual research results to research participants. Empirical research suggests that participants want to know individual research results. On the other hand, the increased resolution and power afforded by new genomic analyses may lead to findings of statistical, but not necessarily clinical, significance. This paper addresses the issues to be considered in deciding whether and how to disclose incidental findings or other findings of clinical significance that arise in the course of human genomic and genetic research. What research results should be offered, and what should not be offered? For which research should individual results be offered to research participants, when should they be offered, how, and to whom?.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据